1. Home
  2. Analysis
  3. Capecitabine
  4. Tobradex

Capecitabine and Tobradex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Capecitabine (capecitabine) and Tobradex (dexamethasone; tobramycin). Common drug interactions include hypertension among females.

The phase IV clinical study analyzes what interactions people have when they take Capecitabine and Tobradex. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Capecitabine?

Capecitabine has active ingredients of capecitabine. eHealthMe is studying from 59,495 Capecitabine users. Check the latest studies of Capecitabine.

What is Tobradex?

Tobradex has active ingredients of dexamethasone; tobramycin. It is often used in eye infection. eHealthMe is studying from 3,154 Tobradex users. Check the latest studies of Tobradex.

On Jul, 08, 2026

12 people who take Capecitabine and Tobradex together, and have interactions are studied.

Capecitabine and Tobradex drug interactions.

What are the common drug interactions of Capecitabine and Tobradex, by gender? *:

female:

  1. Hypertension (high blood pressure)
  2. Metastases to heart (cancer spreads to heart)
  3. Metastases to lung (cancer spreads to lung)
  4. Neuropathy peripheral (surface nerve damage)
  5. Neoplasm malignant (cancer tumour)
  6. Pneumonia
  7. Syncope (loss of consciousness with an inability to maintain postural tone)

male:

n/a

What are the common drug interactions of Capecitabine and Tobradex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Neoplasm malignant (cancer tumour)
  2. Pneumonia

40-49:

  1. Metastases to heart (cancer spreads to heart)
  2. Metastases to lung (cancer spreads to lung)
  3. Neuropathy peripheral (surface nerve damage)
  4. Hypertension (high blood pressure)

50-59:

  1. Syncope (loss of consciousness with an inability to maintain postural tone)

60+:

n/a

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 9 people, 75.00%
  2. Breast Cancer: 3 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Capecitabine and Tobradex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Capecitabine and Tobradex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Capecitabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tobradex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Capecitabine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tobradex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on capecitabine and dexamethasone; tobramycin (the active ingredients of Capecitabine and Tobradex, respectively), and Capecitabine and Tobradex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.